cangrelor
cangrelor
| SMILES | CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O |
| InChIKey | PAEBIVWUMLRPSK-IDTAVKCVSA-N |
Chemical Properties
| Hydrogen bond acceptors | 15 |
| Hydrogen bond donors | 7 |
| Rotatable bonds | 15 |
| Molecular weight (Da) | 774.9 |
Database connections
| Ligand site mutations | P2Y12 |
No bioactivity data available.
cangrelor
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
Phase II
Phase III
Phase IV
Database connections
| Ligand site mutations | P2Y12 |